Document Detail


The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
MedLine Citation:
PMID:  19723907     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We studied patients with systemic lupus erythematosus (SLE) in 1 clinical practice, and patients enrolled in the 1000 Canadian Faces of Lupus database, to determine the minimally important difference (MID) for pain, fatigue, sleep, Health Assessment Questionnaire-Disability Index (HAQ-DI), and Medical Outcomes Study Short Form-36 (SF-36) Physical Component Score (PCS) and SF-36 Mental Component Score (MCS) using a patient-reported overall health status anchor. METHODS: Patients with SLE who had 2 consecutive clinic visits and completed a HAQ-DI and a pain, fatigue, and sleep visual analog scale (VAS) (0-100), and an overall health status question: "How would you describe your overall status since your last visit?": much better, better, the same, worse, or much worse were included. Those who self-rated as better or worse were considered the "minimally changed" subgroups. Patients with 2 consecutive annual visits in the 1000 Canadian Faces of Lupus database who completed the SF-36 and health transition question were eligible. RESULTS: There were 202 patients in London, Ontario (94% women, mean age 50 yrs, mean disease duration 10 yrs). MID for better and worse on a VAS (0-100) were: pain (-15.8, 8.5), fatigue (-13.9, 9.1), and sleep problems (-8.6, 7.6). The MID for HAQ-DI (scale 0 to 3) was -0.08 (better) and 0.14 (worse). The MID for SF-36 was 2.1 (better) and -2.2 (worse) for the PCS and 2.4 (better) and -1.2 (worse) in the MCS. CONCLUSION: The MID in patients with SLE may be different bidirectionally depending on the measured outcome. The mean change observed for those reporting better than worse outcome in pain and fatigue was greater for better versus worst, in contrast to the HAQ, where the mean change was greater for worsening.
Authors:
Kim J Colangelo; Janet E Pope; Christine Peschken
Related Documents :
1259797 - Histocompatibility antigens in systemic lupus erythematosus.
21761957 - The burden of asthma and improving patient outcomes.
12083777 - Identification of autoantibodies associated with systemic lupus erythematosus.
8893147 - Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus...
22882507 - Patients' statements and experiences concerning receiving mechanical ventilation: a pro...
9892747 - Ultrasonographic and biochemical markers of preterm labor.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-01
Journal Detail:
Title:  The Journal of rheumatology     Volume:  36     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-12     Completed Date:  2010-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  2231-7     Citation Subset:  IM    
Affiliation:
Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cohort Studies
Disability Evaluation*
Fatigue / physiopathology,  psychology
Female
Health Status Indicators
Humans
Lupus Erythematosus, Systemic / physiopathology*,  psychology*
Male
Middle Aged
Ontario
Outcome Assessment (Health Care) / methods*
Pain Measurement
Patients*
Self Disclosure*
Severity of Illness Index*
Sleep / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disea...
Next Document:  Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: a hospital-based...